Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Parvinder Thiara | Director | 2024-11-25 | 1,001,633 | $2.73 | $2.73MSell |
Parvinder Thiara | Director | 2024-09-11 | 3,800,000 | $2.70 | $10.26MSell |
Someit Sidhu | Director | 2024-09-04 | 51,728 | $3.87 | $200.19kSell |
Michael Howell | Chief Scientific Officer and Head of Translational Science | 2024-05-18 | 9,860 | $6.05 | $59.65kSell |
Van Amstel Arnout Ploos | Director | 2024-05-17 | 80,000 | $6.20 | $496.00kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Athanor Capital LP | 13.44% | 9,189,633 | $12.59M | Insider |
Parvinder Thiara | 9.95% | 6,801,633 | $9.32M | Insider |
Someit Sidhu | 8.96% | 6,128,590 | $8.40M | Insider |
Hana Immunotherapeutics LLC | 7.90% | 5,404,274 | $7.40M | Insider |
Suvretta Capital Management LLC | 7.11% | 4,860,939 | $6.66M | Institution |
Deep Track Capital LP | 4.80% | 3,283,783 | $4.50M | Institution |
Ra Capital Management LP | 4.71% | 3,217,503 | $4.41M | Institution |
Great Point Partners LLC | 4.64% | 3,170,194 | $4.34M | Institution |
Pfizer Inc | 4.34% | 2,970,022 | $4.07M | Insider |
Pfizer Inc | 4.34% | 2,970,022 | $4.07M | Institution |